Residual insulin secretion at diagnosis of type 1 diabetes is independently associated with both, age of onset and HLA genotype

Diabetes/Metabolism Research and Reviews

Volumn 21, Issue 3, 2005, Pages 271-275

  Petrone, A ^a   Galgani, A ^a   Spoletini, M ^a   Alemanno, I ^a   Di Cola, S ^a   Bassotti, G ^a   Picardi, A ^b   Manfrini, S ^b   Osborn, J ^a   Pozzilli, P ^b   Buzzetti, Raffaella ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Age at onset; Beta cell function; C peptide levels; HLA class II alleles; Residual insulin secretion; Type 1 diabetes

Indexed keywords

C PEPTIDE; HEMOGLOBIN A1C; HLA ANTIGEN CLASS 2; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; INSULIN;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CAUCASIAN; CELL FUNCTION; CHILD; CONTROLLED STUDY; FEMALE; GENETIC RISK; GENOTYPE; HIGH RISK PATIENT; HLA TYPING; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; INFANT; INSULIN; MALE; MIDDLE AGED; RISK FACTORS;

EID: 21044452442     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.549     Document Type: Article

References (28)

1. Laine AP, Nejentsev S, Veijola R. et al. A linkage study of 12 IDDM susceptibility loci in the Finnish population. Diabetes Metab Res Rev 2004; 20: 144-149.
2. Noble JA, Valdes AM, Cook M, et al. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am J Hum Genet 1996; 59: 1134-1148.
3. Sheehy MJ, Scharf SJ, Rowe JR, et al. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest 1989; 83: 830-835.
4. Erlich HA, Zeidler A, Chang J, et al. HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nat Genet 1993; 3: 358-364.
5. Cucca F, Muntoni F, Lampis R, et al. Combinations of specific DRB1, DQA1, DQB1 haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia. Hum Immunol 1993; 37: 85-94.
6. Undlien DE, Friede T, Rammensee HG, et al. HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection. Diabetes 1997; 46: 143-149.
7. Caillat-Zucman S, Dijilali I, Timsit J. et al. Insulin dependent diabetes mellitus (IDDM). In 12th International Histocompatibility Workshop Study in Genetic Diversity of HLA: Functional and Medical Implications, Charron D (ed). EDK Press: Paris, 1997; 389-398.
8. Thorsby E, Ronningen KS. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 371-377.
9. Caillat-Zucman S, Garchon HJ, Timsit J, et al. Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest 1992; 90: 2242-2250.
10. Tait BD, Harrison LC, Drummond BP, et al. HLA antigens and age at diagnosis of insulin-dependent diabetes mellitus. Hum Immunol 1995; 42: 116-122.
11. Lohmann T, Sessler J, Verlohren HJ, et al. Distinct genetic and immunological features in patients with onset of IDDM before and after age 40. Diabetes Care 1997; 20: 524-529.
12. Gillespie KM, Gale EA, Bingley PJ. High familial risk and genetic susceptibility in early onset childhood diabetes. Diabetes 2002; 51: 210-214.
13. Zevaco-Mattei C, Reviron D, Atlan-Gepner C, et al. Relationship between HLA-DQ and -DR genotypes and clinical characteristics in a French population of type 1 diabetic patients. Diabet Med 1999; 16: 201-206.
14. Gambelunghe G, Forini F, Laureti S, et al. Increased risk for endocrine autoimmunity in Italian type 2 diabetics patients with GAD65 autoantibodies. Clin Endocrinol (Oxf) 2000; 52: 565-573.
15. Tuomi T, Carlsson A, Li H, et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 1999; 48: 150-157.
16. Bonfanti R, Bazzigaluppi E, Calori G, et al. Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with type 1 diabetes mellitus. Diabet Med 1998; 15: 844-850.
17. Pozzilli P, Visalli N, Buzzetti R. IMDIAB Study Group. Immunotherapy Diabetes, et al. Metabolic and immune parameters at clinical onset of insulin-dependent diabetes: a population-based study. Metabolism 1998; 47: 1205-1210.
18. Komulainen J, Kulmala P, Savola K. Childhood Diabetes in Finland (DiMe) Study Group, et al. Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Diabetes Care 1999; 22: 1950-1955.
19. Knip M, Ilonen A, Mustonen H, et al. Evidence of an accelerated B-cell destruction in HLA-Dw3/Dw4 heterozygous children with type 1 (insulin-dependent) diabetes. Diabetologia 1986; 29: 347-351.
20. Veijola R, Knip M, Reijonen H, et al. Effect of genetic risk load defined by HLA-DQB1 polymorphism on clinical characteristics of IDDM in children. Eur J Clin Invest 1995; 25: 106-112.
21. Palmer JP, Fleming CA, Greenbaum CJ, et al. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001. Diabetes 2004; 53: 250-264.
22. Buzzetti R, Galgani A, Petrone A, et al. Genetic prediction of type 1 diabetes in a population with low frequency of HLA risk genotypes and low incidence of the disease (the DIABFIN study). Diabetes Metab Res Rev 2004; 20: 137-143.
23. Petrone A, Battelino T, Krzisnik C, et al. Similar incidence of type 1 diabetes in two ethnically different populations (Italy and Slovenia) is sustained by similar HLA susceptible/protective haplotype frequencies. Tissue Antigens 2002; 60: 244-253.
24. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM, et al. CDC growth charts: United States. Adv Data 2000, 314: 1-27.
25. Sjoberg S, Ahren B, Bolinder J. Residual insulin secretion is not coupled to a maintained glucagon response to hypoglycaemia in long-term type 1 diabetes. J Intern Med 2002; 252: 342-351.
26. Chaillous L, Lefevre H, Thivolet C. Diabete Insuline Orale group, et al. Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Lancet 2000; 356: 545-549.
27. Cerna M, Novota P, Kolostova K, et al. HLA in Czech adult patients with autoimmune diabetes mellitus: comparison with Czech children with type 1 diabetes and patients with type 2 diabetes. Eur J Immunogenet 2003; 30: 401-407.
28. Pozzilli P, Visalli N, Picardi A, et al. C-Peptide and HbA1c levels at diagnosis indicate a different pathogenic process depending on the age of onset of type 1 diabetes. Diabetes 2004; 53: A603.